Tag Archives: Novartis
Prix Galien Push for Private/Public Collaboration
Preceding the presentation of the 2009 Prix Galien USA prizes, last Tuesday, a round table discussion was conducted at the American Museum of Natural History on the subject of how public and private collaboration can increase innovation and contribute to saving lives around the world. The talk included Leonard Bell of Alexion Pharmaceuticals, Barry Bloom [...]
Pharma Industry Booming in Eastern Europe
Eastern Europe’s pharmaceutical market is forecast to grow at a CAGR of more than 10 percent to be worth more than $41 billion by 2014, according to a report from globalbusinessinsights.com. The highest sales are expected to be seen in the cardiovascular market ($7.8 billion), followed by alimentary canal and metabolic disorders ($6 billion).
According to [...]
Posted in Global Also tagged business, Czech Republic, Eastern Europe, Pharmaceutical drug, pharmaceutical industry, Sanofi-Aventis, Slovenia 1 Comment
Is a Swine Flu Vaccine Backlash on the Cards?
Image by The Artifex via Flickr
The risk of over-production has paid off: world orders for swine vaccines will see billions of dollars in extra revenue for the biggest pharma companies. GlaxoSmithKline, Roche, Sanofi-Aventis, Novartis, and Baxter are all expected to report very healthy first-half earnings as a result of a wealth of government contracts for [...]
Posted in Global, News Also tagged Add new tag, Andrew Witty, Baxter, GSK, Roche, Swine Flu, vaccine 1 Comment
HBA Leadership Conference: Day 1
Reporting to you from Chicago at the Sixth Annual Healthcare Businesswomen’s Association leadership conference, where the story—set in this city of the new US President—is all about change.
The Pharm Exec crew arrived in a surprisingly tranquil Windy City—the only explanation that it was the calm after the storm of Tuesday’s election. Certainly, many HBA members [...]
Posted in Events Also tagged Chicago, HBA, Johnson & Johnson, leadership, meeting, Obama, PROmedica, Women 1 Comment

Novartis Names Jimenez CEO